Table 6.
Patient | Type of Graft | DLI | MRI Grading | Level of Bile Duct Stricture* | Bile pH | Bile Glucose (mmol/L) | Bile‐Blood pH Difference | Blood‐Bile Glucose Difference | Status |
---|---|---|---|---|---|---|---|---|---|
1 | DBD | 1.15 | Mild | 1 | 7.73 | 0.7 | 0.41 | 7.9 | Alkaline phosphatase resolved |
2 | DCD | 1.49 | Mild | C, 1, and P | 7.33 | 2.4 | 0.16 | 4.8 | Expectant |
3 | DBD | 1.29 | Moderate | C, 1, 2, and P | 7.43 | 2.7 | 0.18 | 3.0 | ERCP plus surgery |
4 | DCD | 1.86 | Moderate | 1, 2, and P | >8 | 8.7 | 0.7 | 6.4 | Expectant |
5 | DCD | 2.02 | Moderate | C, 1, 2, and P | 7.72 | 2.2 | 0.26 | 3.5 | Retransplanted |
6 | DCD | 1.95 | Moderate | C, 1, 2, and P | 7.95 | 10 | 0.7 | 5.6 | Expectant |
7 | DBD‐NESLiP | 0.92 | Moderate | C | 7.87 | 1.6 | 0.67 | 6.5 | Expectant |
8 | DBD | 1.48 | Moderate | C, 1, 2, and P | 7.48 | 2.1 | 0.17 | 5.7 | Retransplanted |
9 | DCD‐NESLiP | 2.04 | Moderate | 1, 2, and P | 7.68 | 1.7 | 0.35 | 7.3 | Expectant |
10 | DCD‐NESLiP | 2.68 | Moderate | C, 1, 2, and P | 7.80 | 2.9 | 0.45 | 2.8 | Relisted |
11 | DCD | 3.13 | Severe | C, 1, 2, and P | 7.74 | 2.5 | 0.39 | 3.7 | Died from recurrent cholangiocarcinoma |
12 | DCD | 1.74 | Severe | C, 1, 2, and P | 7.83 | 6.6 | 0.47 | 2.3 | Retransplanted |
C, bile duct confluence; 1, first‐order ducts; 2, second‐order ducts; and P, peripheral ducts.